Cargando…
Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach
Pancreatic ductal adenocarcinoma (PDAC) represents a challenging pathology with very poor outcomes and is increasing in incidence within the general population. The majority of patients are diagnosed incidentally with insidious symptoms and hence present late in the disease process. This significant...
Autores principales: | Rajesh, Srujan, Cox, Michael J, Runau, Franscois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384751/ https://www.ncbi.nlm.nih.gov/pubmed/34497442 http://dx.doi.org/10.3748/wjg.v27.i31.5171 |
Ejemplares similares
-
Management of early rectal cancer; current surgical options and future direction
por: Chavda, Vijay, et al.
Publicado: (2021) -
Advancements of molecular imaging and radiomics in pancreatic carcinoma
por: Pang, Xiao-Xi, et al.
Publicado: (2023) -
Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis
por: Durkin, Claire, et al.
Publicado: (2019) -
Current role of palliative interventions in advanced pancreatic cancer
por: Ciambella, Chelsey C, et al.
Publicado: (2018) -
Genetic and proteomic approaches to identify cancer drug targets
por: Roti, G, et al.
Publicado: (2012)